Parcopa

DRUG3 trials

Sponsors

UCB Pharma, Baylor College of Medicine

Conditions

Parkinson's Disease

Phase 3

A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease

CompletedNCT00139867

UCB PharmaParkinson's Disease

Start: 2004-01-31End: 2004-05-31Updated: 2014-10-20

A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease

CompletedNCT00139880

UCB PharmaParkinson's Disease

Start: 2005-06-30End: 2005-08-31Updated: 2013-09-04

Phase 4

Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study

CompletedNCT00590122

Baylor College of MedicineParkinson's Disease

Start: 2006-10-31End: 2008-11-30Updated: 2023-03-14